ArticleCancer management and research2018

Clinicopathological significance of DAPK promoter methylation in non-small-cell lung cancer: a systematic review and meta-analysis.

Yan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.